Cargando…

Pharmacological and dietary prevention for colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality. People at higher risk are those individuals with a family history of CRC and familial adenomatous polyposis. Prevention and screening are two milestones for this disease. The aim of this study is to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolfo, Francesca, Rametta, Stefania, Marventano, Stefano, Grosso, Giuseppe, Mistretta, Antonio, Drago, Filippo, Gangi, Santi, Basile, Francesco, Biondi, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851139/
https://www.ncbi.nlm.nih.gov/pubmed/24267792
http://dx.doi.org/10.1186/1471-2482-13-S2-S16
_version_ 1782294233206489088
author Nolfo, Francesca
Rametta, Stefania
Marventano, Stefano
Grosso, Giuseppe
Mistretta, Antonio
Drago, Filippo
Gangi, Santi
Basile, Francesco
Biondi, Antonio
author_facet Nolfo, Francesca
Rametta, Stefania
Marventano, Stefano
Grosso, Giuseppe
Mistretta, Antonio
Drago, Filippo
Gangi, Santi
Basile, Francesco
Biondi, Antonio
author_sort Nolfo, Francesca
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality. People at higher risk are those individuals with a family history of CRC and familial adenomatous polyposis. Prevention and screening are two milestones for this disease. The aim of this study is to evaluate the chemopreventive role of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and cyclooxygenase 2 inhibitors, some micronutrients (folic acid, calcium, selenium, antioxidants) and probiotics. DISCUSSION: The studies on aspiring reported promising results, but it is debatable whether aspirin should be used as chemoprevention, because of its side effects and because of poor efficacy evident in subjects at high risk. Similar results were reported for other non-aspirin NSAIDs, such as sulindac and celecoxib, which the potential adverse effects limit their use. Selenium role in prevention of various types of cancer as well as in colon adenomas are often inconclusive or controversial. Several studies suggested that calcium may have a possible chemopreventive effect on colon adenomas and CRC, although contrasting results are reported for the latter. A recent meta-analysis including 13 randomized trial suggested that folic acid supplementation had not a chemiopreventive action on CRC. Several studies investigated the association between antioxidants, administered alone or in combination, and CRC risk, both among general and at risk population, but only few of them supported statistically significant results. CONCLUSION: The results of this literature review showed an unclear role in CRC prevention of both pharmacological and dietary intervention. Despite several options are available to prevent colon cancer, it is challenging to identify a correct strategy to prevent CRC through pharmacological and dietary intervention due to the long latency of cancer promotion and development. Since some of the drugs investigated may have uncertain individual effects, it can be suggested to potentiate such effects by adding them together.
format Online
Article
Text
id pubmed-3851139
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38511392013-12-13 Pharmacological and dietary prevention for colorectal cancer Nolfo, Francesca Rametta, Stefania Marventano, Stefano Grosso, Giuseppe Mistretta, Antonio Drago, Filippo Gangi, Santi Basile, Francesco Biondi, Antonio BMC Surg Research Article BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality. People at higher risk are those individuals with a family history of CRC and familial adenomatous polyposis. Prevention and screening are two milestones for this disease. The aim of this study is to evaluate the chemopreventive role of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and cyclooxygenase 2 inhibitors, some micronutrients (folic acid, calcium, selenium, antioxidants) and probiotics. DISCUSSION: The studies on aspiring reported promising results, but it is debatable whether aspirin should be used as chemoprevention, because of its side effects and because of poor efficacy evident in subjects at high risk. Similar results were reported for other non-aspirin NSAIDs, such as sulindac and celecoxib, which the potential adverse effects limit their use. Selenium role in prevention of various types of cancer as well as in colon adenomas are often inconclusive or controversial. Several studies suggested that calcium may have a possible chemopreventive effect on colon adenomas and CRC, although contrasting results are reported for the latter. A recent meta-analysis including 13 randomized trial suggested that folic acid supplementation had not a chemiopreventive action on CRC. Several studies investigated the association between antioxidants, administered alone or in combination, and CRC risk, both among general and at risk population, but only few of them supported statistically significant results. CONCLUSION: The results of this literature review showed an unclear role in CRC prevention of both pharmacological and dietary intervention. Despite several options are available to prevent colon cancer, it is challenging to identify a correct strategy to prevent CRC through pharmacological and dietary intervention due to the long latency of cancer promotion and development. Since some of the drugs investigated may have uncertain individual effects, it can be suggested to potentiate such effects by adding them together. BioMed Central 2013-10-08 /pmc/articles/PMC3851139/ /pubmed/24267792 http://dx.doi.org/10.1186/1471-2482-13-S2-S16 Text en Copyright © 2013 Nolfo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nolfo, Francesca
Rametta, Stefania
Marventano, Stefano
Grosso, Giuseppe
Mistretta, Antonio
Drago, Filippo
Gangi, Santi
Basile, Francesco
Biondi, Antonio
Pharmacological and dietary prevention for colorectal cancer
title Pharmacological and dietary prevention for colorectal cancer
title_full Pharmacological and dietary prevention for colorectal cancer
title_fullStr Pharmacological and dietary prevention for colorectal cancer
title_full_unstemmed Pharmacological and dietary prevention for colorectal cancer
title_short Pharmacological and dietary prevention for colorectal cancer
title_sort pharmacological and dietary prevention for colorectal cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851139/
https://www.ncbi.nlm.nih.gov/pubmed/24267792
http://dx.doi.org/10.1186/1471-2482-13-S2-S16
work_keys_str_mv AT nolfofrancesca pharmacologicalanddietarypreventionforcolorectalcancer
AT ramettastefania pharmacologicalanddietarypreventionforcolorectalcancer
AT marventanostefano pharmacologicalanddietarypreventionforcolorectalcancer
AT grossogiuseppe pharmacologicalanddietarypreventionforcolorectalcancer
AT mistrettaantonio pharmacologicalanddietarypreventionforcolorectalcancer
AT dragofilippo pharmacologicalanddietarypreventionforcolorectalcancer
AT gangisanti pharmacologicalanddietarypreventionforcolorectalcancer
AT basilefrancesco pharmacologicalanddietarypreventionforcolorectalcancer
AT biondiantonio pharmacologicalanddietarypreventionforcolorectalcancer